16:54 EDT Tracon Pharmaceuticals files to sell common stock, warrants, no amount given
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCON:
- TRACON Pharmaceuticals trading halted, news pending
- TRACON Pharmaceuticals Announces Reverse Stock Split
- Tracon Pharmaceuticals announces 1-for-20 reverse stock split
- Tracon Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
- Tracon says IDMC reccommends ENVASARC Phase 2 trial continue ‘as planned’